tiprankstipranks
Trending News
More News >
CryoPort Inc (CYRX)
:CYRX
US Market
Advertisement

CryoPort (CYRX) Earnings Dates, Call Summary & Reports

Compare
637 Followers

Earnings Data

Report Date
Nov 06, 2025
After Close (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
-0.22
Last Year’s EPS
-0.02
Same Quarter Last Year
Based on 7 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
Cryoport's earnings call reflects strong revenue growth and strategic advancements, particularly through the DHL partnership, despite some challenges with a client's therapy pause and regulatory setbacks. The overall business outlook remains positive with continued focus on innovation and global expansion.
Company Guidance
During Cryoport's second quarter 2025 earnings call, the company reported strong financial performance, highlighting a 21% year-over-year increase in service revenue, which accounted for 54% of total revenue from continuing operations. Key growth areas included a 33% rise in revenue from commercial cell and gene therapies and a 28% increase in BioStorage/BioServices. The Life Sciences products segment saw an 8% year-over-year revenue growth, driven by demand from animal health customers. Overall, total revenue from operations increased by 14%, with improvements in gross margin and adjusted EBITDA. Despite a temporary pause in distribution by a gene therapy client, Cryoport reaffirmed its full-year 2025 revenue guidance, citing broad support for 728 clinical trials and the strategic partnership with DHL Group as significant drivers of future growth.
Strong Revenue Growth
Cryoport reported a 14% increase in total revenue from operations for the second quarter, with a 21% year-over-year increase in service revenue and a 33% increase in revenue from commercial cell and gene therapies.
Successful Strategic Partnership with DHL
Cryoport launched a strategic partnership agreement with DHL Group, including a $200 million cash infusion from the sale of CRYOPDP to DHL, enhancing global bio logistics capabilities.
Increased Clinical Trial Support
Cryoport supported a record 728 clinical trials, approximately 70% of the industry cell and gene therapy trials, with the expectation of up to 20 application filings and one new therapy approval for the remainder of 2025.
Product Innovation
Launch of next-generation MVE SC 4/2 and SC 4/3 vapor shippers and MVE's high-efficiency 800-seat cryogenic storage system, supporting improved safety and reliability in transporting sensitive biological materials.
Improved Financial Metrics
Significant increase in gross margin and a meaningful lift in adjusted EBITDA due to profitability initiatives, with a reported 47% total gross margin.

CryoPort (CYRX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CYRX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 06, 2025
2025 (Q3)
-0.22 / -
-0.02
Aug 05, 2025
2025 (Q2)
-0.26 / 2.05
-1.62226.54% (+3.67)
May 07, 2025
2025 (Q1)
-0.34 / -0.28
-0.4334.88% (+0.15)
Mar 04, 2025
2024 (Q4)
-0.29 / -0.42
-1.3167.94% (+0.89)
Nov 07, 2024
2024 (Q3)
-0.31 / -0.02
-0.3193.55% (+0.29)
Aug 06, 2024
2024 (Q2)
-0.40 / -1.62
-0.42-285.71% (-1.20)
May 07, 2024
2024 (Q1)
-0.34 / -0.43
-0.16-168.75% (-0.27)
Mar 12, 2024
2023 (Q4)
-0.28 / -1.31
-0.24-445.83% (-1.07)
Nov 08, 2023
2023 (Q3)
-0.32 / -0.31
-0.15-106.67% (-0.16)
Aug 09, 2023
2023 (Q2)
-0.24 / -0.42
-0.23-82.61% (-0.19)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CYRX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 05, 2025
$6.74$8.75+29.82%
May 07, 2025
$5.66$6.98+23.32%
Mar 04, 2025
$5.06$6.61+30.63%
Nov 07, 2024
$8.02$7.73-3.62%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does CryoPort Inc (CYRX) report earnings?
CryoPort Inc (CYRX) is schdueled to report earning on Nov 06, 2025, After Close (Confirmed).
    What is CryoPort Inc (CYRX) earnings time?
    CryoPort Inc (CYRX) earnings time is at Nov 06, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CYRX EPS forecast?
          CYRX EPS forecast for the fiscal quarter 2025 (Q3) is -0.22.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis